These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program. Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS Neurosci Behav Physiol; 2022; 52(6):836-841. PubMed ID: 36311877 [No Abstract] [Full Text] [Related]
4. [Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia]. Abramenko YV Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):59-64. PubMed ID: 32307432 [TBL] [Abstract][Full Text] [Related]
5. [Improvement of the efficacy of treatment of hypertensive encephalohathy by using mexidol]. Bolotova EV; Lushpay NY; Kovrigina IV Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4):61-64. PubMed ID: 29863694 [TBL] [Abstract][Full Text] [Related]
6. [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX]. Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):84-90. PubMed ID: 35175707 [TBL] [Abstract][Full Text] [Related]
7. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia]. Kutashov VA; Ulyanova OV Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723 [TBL] [Abstract][Full Text] [Related]
8. [Neurological disorders in the postcovid period]. Fedin AI Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):31-37. PubMed ID: 36279226 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain]. Chukanova EI; Chukanova AS Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):39-45. PubMed ID: 31626217 [TBL] [Abstract][Full Text] [Related]
10. [Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19]. Kovalchuk VV; Ershova II; Molodovskaya NV Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):60-66. PubMed ID: 33908234 [TBL] [Abstract][Full Text] [Related]
11. [Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis]. Vizilo TL; Arefieva EG Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):51-55. PubMed ID: 36946397 [TBL] [Abstract][Full Text] [Related]
12. [The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke]. Strelnikova IA; Svetkina AA; Androfagina OV Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):54-58. PubMed ID: 32307431 [TBL] [Abstract][Full Text] [Related]
13. [Neurological aspects of the consequences of COVID-19 in children]. Nemkova SA Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(4):23-30. PubMed ID: 35485061 [TBL] [Abstract][Full Text] [Related]
15. [The efficacy of mexidol for transient ischemic attacks in the vertebrobasilar system in elderly patients with chronic cerebral ischemia]. Abramenko YV Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9. Vyp. 2):42-48. PubMed ID: 30499559 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia]. Zhuravleva MV; Prokofiev AB; Serebrova SY; Vasyukova NS; Demchenkova EY; Arkhipov VV Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):119-124. PubMed ID: 32678558 [TBL] [Abstract][Full Text] [Related]
17. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia]. Berezhnaya SV; Yakupov EZ; Zaharov YA Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176 [TBL] [Abstract][Full Text] [Related]
18. [The efficacy of mexidol in carotid endarterectomy procedure in patients with cerebral atherosclerotic stenosis]. Golovkin VI; Svetlikov AV; Shapovalov AS; Popova LO Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(1):51-55. PubMed ID: 26977626 [TBL] [Abstract][Full Text] [Related]
19. [The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia]. Berezhnaya SV; Yakupov EZ Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):48-52. PubMed ID: 26356397 [TBL] [Abstract][Full Text] [Related]
20. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy]. Abramenko IuV Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]